United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News How FDA-aligned endpoints position inFoods IBS alongside drug therapies Biomerica, Inc. aligns inFoods IBS with FDA drug endpoints and secures Medicare pricing. See what this means for IBS competitors and investors. bySoujanya RaviMarch 1, 2026